Provided by Tiger Trade Technology Pte. Ltd.

Gain Therapeutics, Inc.

1.73
+0.05002.98%
Volume:787.47K
Turnover:1.39M
Market Cap:75.50M
PE:-3.40
High:1.84
Open:1.70
Low:1.69
Close:1.68
52wk High:4.34
52wk Low:1.53
Shares:43.64M
Float Shares:42.34M
Volume Ratio:1.35
T/O Rate:1.86%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5092
EPS(LYR):-0.6115
ROE:-268.30%
ROA:-95.51%
PB:6.69
PE(LYR):-2.83

Loading ...

Gain Therapeutics to Present Long-Term Phase 1b Extension Data for Parkinson’s Drug Rexaceract at MDS Congress

Reuters
·
Yesterday

Gain Therapeutics Names CEO as Interim CFO

TIPRANKS
·
Sep 29

Gain Therapeutics - Gene Mack to Continue as President and CEO While Serving as Interim CFO - SEC Filing

THOMSON REUTERS
·
Sep 29

Gain Therapeutics - Gianluca Fuggetta to Resign as Principal Financial Officer Effective Sept 30, 2026 - SEC Filing

THOMSON REUTERS
·
Sep 29

Gain Therapeutics - Appoints Gene Mack as Interim CFO Effective Oct 1, 2026 - SEC Filing

THOMSON REUTERS
·
Sep 29

Gain Therapeutics CEO Gene Mack Takes Interim CFO Role After Fuggetta Resignation

Reuters
·
Sep 29

Gain Therapeutics CEO Joins ROTH Healthcare Opportunities Conference Panel

Reuters
·
Sep 17

Gain Therapeutics Price Target Maintained with a $8.00/Share by HC Wainwright & Co.

Dow Jones
·
Aug 31

Gain Therapeutics Joins H.C. Wainwright Global Investment Conference for Investor Meetings

Reuters
·
Aug 25

Analysts Offer Insights on Healthcare Companies: Gain Therapeutics (GANX) and Prothena (PRTA)

TIPRANKS
·
Aug 15

Gain Therapeutics (GANX) Gets a Buy from Oppenheimer

TIPRANKS
·
Aug 13

Inovio Q2 Net Loss Narrows on Warrant Gain, Lower Costs

Reuters
·
Aug 13

BTIG Sticks to Their Buy Rating for Gain Therapeutics (GANX)

TIPRANKS
·
Aug 12

Acumen Pharmaceuticals Q2 Net Loss Widens, Misses Analyst Estimates

Reuters
·
Aug 12

Gain Therapeutics Price Target Maintained with a $5.00/Share by BTIG

Dow Jones
·
Aug 12

U.S. Stocks on the MOVEX-Abbott, Columbia Financial, Jabil,

Reuters
·
Aug 11

Gain Therapeutics Climbs on Narrower-than-Expected Quarterly Loss

Reuters
·
Aug 11

Gain Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 11

Neurogene Q2 Adjusted Loss Per Share Misses Estimates on Employee Costs

Reuters
·
Aug 11

Gain Therapeutics Q2 EPS $(0.11) Beats $(0.14) Estimate

Benzinga Earnings
·
Aug 11